Roche Touts 10-Minute Ocrevus Benefits For MS
Filings Imminent
A subcutaneous version of Ocrevus is as effective as the intravenous form of Roche's biggest seller, and could boost access of the multiple sclerosis drug where access to intravenous clinics is problematic.
